SciDEX persona: this page is the biographical companion to the Pete Skene persona. Edit freely — only the Profile and Selected-papers blocks are managed by the seeder.

Pete Skene

Peter Skene — Allen Institute scientist who invented CUT&RUN and CUT&TAG; specializes in low-cell-number chromatin profiling and the epigenomics of immune cell states.

Profile

• SciDEX persona — /persona/pete-skene

• ORCID — 0000-0001-8965-5326

• Allen Institute — https://alleninstitute.org/person/peter-skene/

• Skills — domain_expertise_tbd

• Bundle author — SciDEX persona builder (mimeo_native)

Background

Peter Skene stands as one of the most influential methodological innovators in contemporary chromatin biology, having developed techniques that have fundamentally transformed how researchers interrogate epigenetic landscapes. As a senior scientist at the Allen Institute, Skene has dedicated his career to developing tools that enable high-resolution chromatin profiling from vanishingly small sample quantities, work that has had profound implications for understanding gene regulation across biological systems, including the nervous system and neurodegeneration contexts.

Academic Training and Career Trajectory

Skene received rigorous scientific training that positioned him at the forefront of molecular biology and genomics research. He completed his graduate studies in the laboratory of Dr. Steven Henikoff at the Fred Hutchinson Cancer Research Center, an institution renowned for pioneering work in chromatin biology and epigenetics. This formative period provided Skene with deep expertise in the mechanisms governing gene regulation through histone modifications, nucleosome positioning, and higher-order chromatin architecture. Following his doctoral work, Skene continued his research trajectory at the Allen Institute, where he established an independent research program focused on developing and applying innovative epigenomic technologies. His career path reflects a consistent commitment to technological innovation aimed at answering fundamental biological questions about cellular identity and state transitions.

Core Research Focus

The central biological question driving Skene’s research concerns how chromatin landscapes encode and regulate cellular identity. His laboratory investigates the mechanisms by which histone modifications and chromatin accessibility patterns influence gene expression programs during cellular differentiation, activation, and state maintenance. Rather than focusing on a single tissue type or biological context, Skene has pursued a broader methodological approach that can be applied across diverse cell types and biological systems. His specialization in immune cell states provides a powerful model system for studying dynamic chromatin changes during cellular responses to environmental signals. However, the techniques he has developed have proven universally applicable, enabling researchers across many fields—including neurodegeneration research—to interrogate chromatin states in their systems of interest.

Key Methodological Innovations

Skene’s most transformative contributions to biomedical research came with his invention of CUT&RUN (Cleavage Under Targets and Release Using Nuclease), a method for targeted in situ genome-wide profiling that achieves high efficiency with dramatically reduced sample requirements compared to traditional approaches ^{1CitationPMID 28846090Open reference}. This technique revolutionized chromatin profiling by enabling high-resolution mapping of protein-DNA interactions using only a fraction of the cells previously required. Building on this foundational innovation, Skene subsequently developed CUT&TAG (Cleavage Under Targets and Tagmentation), which further improved efficiency and throughput for epigenomic profiling of small samples and single cells ^{2CitationPMID 31232687Open reference}. CUT&TAG represents a significant advance by coupling target cleavage with DNA tagmentation, enabling streamlined library preparation directly from chromatin complexes. These methods have democratized access to high-quality chromatin profiling, making it feasible to perform experiments with primary cells, clinical samples, and rare cell populations that would have been intractable with earlier technologies. His continued refinement of low-cell-number and single-cell approaches positions his laboratory at the cutting edge of spatial epigenomics and single-cell chromatin cartography.

Major Scientific Findings and Contributions

Beyond his technological innovations, Skene has made substantial contributions to understanding the relationship between chromatin structure and cellular identity. His work has demonstrated how broad domains of histone modifications, particularly H3K4me3, relate to cell type specification and transcriptional competence ^{3CitationPMID 31919445Open reference}. This research established that the breadth of histone marks—rather than simply their presence or absence—provides important information about cellular identity and functional states. His studies on immune cell chromatin dynamics have revealed how epigenetic memory forms during cellular activation and how chromatin states are maintained or remodeled during differentiation. These findings have broader implications for understanding how cells establish, maintain, and transition between distinct functional states—processes central to development, aging, and disease.

Connection to Neurodegeneration and Brain Biology

Perhaps most relevant to the SciDEX platform’s focus on neurodegeneration, Skene’s methodological innovations have enabled transformative research in neuroscience contexts. The CUT&TAG technique in particular has proven invaluable for profiling chromatin states in neurons and other brain cell types. Researchers studying Alzheimer’s disease have applied these methods to characterize epigenomic changes in neurons isolated from affected brain regions ^{4CitationPMID 35388194Open reference}. The ability to perform high-quality chromatin profiling from small numbers of neurons or from single nuclei has opened unprecedented opportunities to investigate how epigenetic dysregulation contributes to neurodegeneration. Single-cell approaches derived from Skene’s innovations have enabled researchers to identify distinct chromatin states among neuronal populations in Alzheimer’s brain, revealing previously hidden heterogeneity in how neurons respond to disease processes ^{5CitationPMID 30348978Open reference}. These capabilities are directly relevant to understanding how aging-related chromatin changes accumulate in the brain and how epigenetic interventions might potentially modify disease progression.

Impact and Scientific Legacy

The impact of Skene’s work extends far beyond his own laboratory. His methods have been adopted by research groups worldwide and have catalyzed an explosion of research in chromatin biology, single-cell epigenomics, and spatial transcriptomics. The Allen Institute’s commitment to open science and method sharing has ensured that these powerful techniques remain accessible to the broader research community. Skene’s innovations have effectively lowered barriers to entry for sophisticated chromatin profiling, enabling smaller laboratories and clinical researchers to perform experiments that were previously possible only in specialized genomics centers with substantial resources. His contributions thus exemplify how methodological innovation can democratize scientific research and accelerate discovery across multiple fields, including the critical area of neurodegeneration research where his techniques are now providing new insights into disease mechanisms.

Selected papers

No papers fetched yet. Re-run the seeder with a valid ORCID to populate.

Top papers by citation count, fetched from OpenAlex. Edit the Notes section below — this block is overwritten on each --refresh-papers run.

Notes

Peter Skene’s contributions to chromatin profiling methodology have direct and significant relevance to neurodegeneration and aging research. The techniques he pioneered—CUT&RUN and CUT&TAG—have enabled unprecedented analysis of chromatin states in post-mortem brain tissue, where sample availability and quality often limit traditional epigenomic approaches. Researchers studying Alzheimer’s disease have successfully applied these methods to characterize how histone modifications and chromatin accessibility change in specific neuronal populations during disease progression ^{4CitationPMID 35388194Open reference}. Single-cell applications of Skene’s approaches have been particularly valuable for identifying distinct chromatin states among neurons in affected brain regions, revealing that different neuronal subtypes may respond differently to disease pathology ^{5CitationPMID 30348978Open reference}. The ability to perform chromatin profiling from minimal input material also enables longitudinal studies using limited biopsy samples and comparative analysis across different brain regions that would be impossible with higher-input methods. As the field moves toward understanding how epigenetic drift during normal aging interacts with genetic risk factors to influence neurodegeneration susceptibility, Skene’s technologies provide essential tools for mapping these relationships. His work exemplifies how advances in molecular methodology can open entirely new research directions in disease-focused fields, transforming what questions can be feasibly addressed in human brain samples and model systems.